Description
Compound Amino Acid Injection (18AA-VII) is a sterile, non-pyrogenic amino acid solution used for parenteral nutrition in patients unable to consume adequate nutrients orally or enterally. Each 200ml bottle delivers 20.65 grams of total amino acids, formulated to support protein synthesis, nitrogen balance, and tissue repair during illness, surgery, trauma, or malnutrition.
Manufactured under GMP standards by Anhui Fubang Pharmaceutical Co., Ltd., this formula includes 18 essential and non-essential amino acids, making it suitable for hospital use, clinical nutrition therapy, and emergency care settings. Ideal for intravenous administration by trained healthcare professionals.
This product is supplied in a single-use glass bottle and is available for bulk orders and retail distribution.
Mechanism of Action
Amino acids are the building blocks of proteins. When administered intravenously, they bypass the gastrointestinal tract and enter systemic circulation directly, supplying essential substrates for tissue repair, enzyme production, hormonal synthesis, and immune function. The formulation helps maintain positive nitrogen balance, especially in catabolic states.
Compound Amino Acid Injection Product Parameters
| Parameter | Description |
|---|---|
| Product Name | Compound Amino Acid Injection (18AA-VII) |
| Amino Acid Content | 20.65g of total amino acids per 200ml |
| Specification | 200ml per bottle |
| Dosage Form | Injection (IV use only) |
| Administration Route | Intravenous Infusion |
| Approval Number | H20123185 |
| Drug Code | 86909617000017 |
| Manufacturer | Anhui Fubang Pharmaceutical Co., Ltd. |
| Country of Origin | China |
| Packaging Unit | Bottle |
| Storage Conditions | Store below 25°C, avoid freezing |
| Shelf Life | Typically 24–36 months (see packaging) |
| CAS Numbers (Main AAs) | L-Leucine: 61-90-5, L-Valine: 72-18-4, L-Isoleucine: 73-32-5 |
| Intended Use | Parenteral nutrition, amino acid supplementation |
Compound Amino Acid Injection Possible Side Effects
Fever or chills
Local phlebitis or injection site irritation
Electrolyte imbalance (if improperly monitored)
Hyperammonemia (in cases of liver dysfunction)
Nausea or mild GI discomfort (rare)
All IV infusions should be administered under professional supervision.
Disclaimer
This product information is intended for experimental and wholesale listing purposes only. It is not a substitute for professional medical advice or diagnosis. Use only as directed by a qualified healthcare provider. Always follow national and local regulations regarding the use and administration of injectable pharmaceuticals.


Reviews
There are no reviews yet.